In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cells
Open Access
- 16 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 16 (7), 809-813
- https://doi.org/10.1038/nm.2154
Abstract
Transplant arteriosclerosis is a leading cause of transplanted organ dysfunction. Human regulatory T cells expanded ex vivo can prevent transplant arteriosclerosis in a mouse model by preventing the immune infiltration of the graft. Transplant arteriosclerosis is the hallmark of chronic allograft dysfunction (CAD) affecting transplanted organs in the long term1,2. These fibroproliferative lesions lead to neointimal thickening of arteries in all transplanted allografts2. Luminal narrowing then leads to graft ischemia and organ demise. To date, there are no known tolerance induction strategies that prevent transplant arteriosclerosis3,4. Therefore, we designed this study to test the hypothesis that human regulatory T cells (Treg cells) expanded ex vivo can prevent transplant arteriosclerosis. Here we show the comparative capacity of Treg cells, sorted via two separate strategies, to prevent transplant arteriosclerosis in a clinically relevant chimeric humanized mouse system. We found that the in vivo development of transplant arteriosclerosis in human arteries was prevented by treatment of ex vivo–expanded human Treg cells. Additionally, we show that Treg cells sorted on the basis of low expression of CD127 provide a more potent therapy to conventional Treg cells. Our results demonstrate that human Treg cells can inhibit transplant arteriosclerosis by impairing effector function and graft infiltration. We anticipate our findings to serve as a foundation for the clinical development of therapeutics targeting transplant arteriosclerosis in both allograft transplantation and other immune-mediated causes of vasculopathy5.This publication has 28 references indexed in Scilit:
- Expansion of Human Regulatory T-Cells From Patients With Type 1 DiabetesDiabetes, 2009
- Homeostatic Repopulation by CD28−CD8+ T Cells in Alemtuzumab-Depleted Kidney Transplant Recipients Treated With Reduced ImmunosuppressionAmerican Journal of Transplantation, 2008
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsThe Journal of Experimental Medicine, 2006
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsThe Journal of Experimental Medicine, 2006
- Radial artery conduits for coronary artery bypass grafting: Current perspectiveThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cellsBlood, 2004
- Regulatory T cells in transplantation toleranceNature Reviews Immunology, 2003
- Dominant transplantation tolerance impairs CD8+ T cell function but not expansionNature Immunology, 2002
- Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation modelKidney International, 1998
- Development of a mouse aortic transplant model of chronic rejectionMicrosurgery, 1995